SanBio Company Limited (TYO:4592)

SanBio Company Ratios and Metrics

Market cap in millions JPY. Fiscal year is February - January.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 26, 2026	Jan 31, 2026	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022
Market Capitalization	146,702	144,283	51,067	37,882	47,323	56,092
Market Cap Growth	76.93%	182.53%	34.81%	-19.95%	-15.63%	-33.83%
Enterprise Value	132,857	143,674	49,493	34,808	42,917	52,423
Last Close Price	1880.00	1849.00	720.00	566.00	744.00	1083.00
PB Ratio	10.78	10.61	28.98	13.57	10.69	27.56
P/TBV Ratio	10.82	10.64	29.71	13.78	10.69	28.49
Debt / Equity Ratio	0.09	0.09	0.23	0.24	0.21	1.24
Net Debt / Equity Ratio	-1.02	-1.02	-1.43	-1.36	-1.31	-1.00
Net Debt / EBITDA Ratio	3.66	3.66	0.72	0.84	0.74	0.31
Net Debt / FCF Ratio	3.65	3.65	0.70	0.79	0.78	0.31
Quick Ratio	28.25	28.25	3.99	4.92	6.18	3.12
Current Ratio	29.01	29.01	4.56	5.46	6.39	3.66
Return on Equity (ROE)	-50.00%	-50.00%	-126.57%	-73.24%	-172.03%	-90.08%
Return on Assets (ROA)	-24.87%	-24.87%	-51.74%	-46.92%	-78.64%	-43.89%
Return on Capital Employed (ROCE)	-25.10%	-25.10%	-129.50%	-109.60%	-132.60%	-163.60%
Earnings Yield	-2.62%	-2.66%	-5.64%	-6.98%	-11.75%	-8.34%
FCF Yield	-2.58%	-2.63%	-7.06%	-12.61%	-15.72%	-11.74%
Buyback Yield / Dilution	-6.17%	-6.17%	-5.42%	-12.78%	-11.83%	-0.01%

Updated Jan 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.